|
VPS45 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.62019999999852E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.582600E-04 |
| Normal-vs-Stage2 |
5.440500E-03 |
| Normal-vs-Stage3 |
7.67260000000825E-05 |
| Normal-vs-Stage4 |
3.782800E-04 |
| Stage1-vs-Stage2 |
6.845000E-01 |
| Stage1-vs-Stage3 |
1.900030E-01 |
| Stage1-vs-Stage4 |
3.507200E-01 |
| Stage2-vs-Stage3 |
6.161600E-01 |
| Stage2-vs-Stage4 |
6.837600E-01 |
| Stage3-vs-Stage4 |
9.314400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.4855999999639E-06 |
| Normal-vs-AfricanAmerican |
2.859600E-01 |
| Normal-vs-Asian |
6.813800E-02 |
| Caucasian-vs-AfricanAmerican |
9.834200E-02 |
| Caucasian-vs-Asian |
1.164210E-01 |
| AfricanAmerican-vs-Asian |
6.832600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.983800E-03 |
| Normal-vs-Female |
2.02320000000089E-05 |
| Male-vs-Female |
4.770600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.975910E-04 |
| Normal-vs-Age(41-60Yrs) |
1.156330E-04 |
| Normal-vs-Age(61-80Yrs) |
1.697230E-03 |
| Normal-vs-Age(81-100Yrs) |
1.343750E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.217000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.323600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.605200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.902200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.186800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.985800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.655800E-03 |
| Classical-VS-Follicular |
6.466800E-01 |
| Classical-VS-Other |
7.059400E-01 |
| Classical-VS-Normal |
4.158600E-04 |
| Tall-VS-Follicular |
1.704010E-03 |
| Tall-VS-Other |
2.276200E-01 |
| Tall-VS-Normal |
1.15309999992874E-07 |
| Follicular-VS-Other |
6.442200E-01 |
| Follicular-VS-Normal |
1.949740E-02 |
| Other-VS-Normal |
6.353900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.59450000000772E-05 |
| Normal-vs-N1 |
4.569000E-04 |
| N0-vs-N1 |
5.976000E-01 |
|
|
